Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 125,189	$ 56,776
Restricted cash equivalents	5,577	3,355
Marketable securities, at fair value	42,774	50,535
Restricted marketable securities, at fair value	30,352	25,105
Accounts receivable (less allowances: $119,305 and $87,520)	281,303	330,907
Notes receivable — short–term portion (less allowances: $25,931 and $10,372)	31,243	51,429
Inventories and supplies	16,797	16,749
Income taxes receivable	22,246	0
Prepaid expenses and other current assets	20,934	21,796
Total current assets	576,415	556,652
Property and equipment, net	27,586	28,198
Goodwill	79,797	75,529
Other intangible assets (less accumulated amortization of $42,931 and $39,242)	6,964	9,442
Notes receivable — long–term portion (less allowances: $1,776 and $2,890)	25,209	41,054
Deferred compensation funding, at fair value	55,909	49,639
Deferred tax assets	18,472	38,170
Other long-term assets	3,901	4,088
Total assets	794,253	802,772
Current liabilities:
Accounts payable	77,382	81,147
Accrued payroll and related taxes	31,400	51,579
Other accrued expenses and current liabilities	37,222	26,282
Income taxes payable	0	8,391
Accrued insurance claims	24,371	25,148
Total current liabilities	170,375	192,547
Accrued insurance claims — long-term	46,142	51,869
Deferred compensation liability — long-term	56,276	50,011
Lease liability — long-term	9,659	8,033
Other long-term liabilities	1,591	385
Commitments and contingencies (Note 17)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 200,000 shares authorized; 76,821 and 76,533 shares issued, and 69,596 and 73,203 shares outstanding	768	765
Additional paid-in capital	327,956	318,363
Retained earnings	283,668	224,556
Accumulated other comprehensive loss, net of taxes	(448)	(2,317)
Common stock in treasury, at cost; 7,225 and 3,330 shares	(101,734)	(41,440)
Total stockholders’ equity	510,210	499,927
Total liabilities and stockholders’ equity	$ 794,253	$ 802,772